You should read the following discussion and analysis of our financial condition
and results of operations in conjunction with our financial statements and
related notes included in Part II, Item 8 of this Annual Report on
Form 10-K/A.
Overview
We are a blank check company incorporated in Delaware on July 31, 2020. We were
formed for the purpose of effecting a merger, share exchange, asset acquisition,
share purchase, reorganization or similar business combination with one or more
businesses, or the initial business combination. We are an "emerging growth
company," as defined in Section 2(a) of the Securities Act of 1933, as amended,
as modified by the Jumpstart Our Business Startups Act of 2012 and, as such, we
are subject to all of the risks associated with early stage and emerging growth
companies.

                                       60

--------------------------------------------------------------------------------

Table of Contents


  Index to Financial Statements
As of December 31, 2020, we had not commenced any operations. All activity for
the period from July 31, 2020 (inception) through December 31, 2020 relates to
our formation and our IPO. We will not generate any operating revenues until
after the consummation of our initial Business Combination, at the earliest. We
generate non-operating income
in the form of interest income on cash and cash equivalents from the proceeds
derived from the IPO. We have selected December 31 as our fiscal year end.
Our sponsor is Thayer Ventures Acquisition Holdings LLC, a Delaware limited
liability company. The registration statement for our IPO was declared effective
on December 10, 2020. On December 15, 2020, we closed the IPO and issued
17,250,000 units, which included 2,250,000 additional units to cover an
over-allotment option we granted to the underwriters, at $10.00 per unit,
generating gross proceeds of $172.5 million, and incurring offering costs of
$9.2 million, inclusive of $6.9 million in deferred underwriting commissions and
net of reimbursement from underwriters of $1.7 million. We refer to the shares
of Class A common stock included in the units as the public shares.
Simultaneously with the closing of the IPO, we consummated a private placement
of 7,175,000 warrants, at a price of $1.00 per private placement warrant, to our
sponsor, generating proceeds of $7.2 million.
Upon the closing of the IPO and the private placement, $176.0 million ($10.20
per unit) of the net proceeds of the IPO and certain of the proceeds from the
private placement were placed in a trust account located in the United States
with Continental Stock Transfer & Trust Company acting as trustee, which will be
invested only in U.S. government treasury obligations with a maturity of
185 days or less or in money market funds meeting certain conditions
under Rule 2a-7 under
the Investment Company Act of 1940, which invest only in direct U.S. government
treasury obligations, as determined by us, until the earlier of: (i) the
completion of a business combination and (ii) the distribution of the trust
account as described below.
If we are unable to complete a business combination before June 15, 2022, which
is 18 months from the closing of our IPO, and our stockholders have not amended
our certificate of incorporation to extend such date, we will (i) cease all
operations except for the purpose of winding up; (ii) as promptly as reasonably
possible, but not more than ten business days thereafter, redeem the public
shares, at
a per-share price,
payable in cash, equal to the aggregate amount then on deposit in the trust
account, including interest (less taxes payable and up to $100,000 of interest
to pay dissolution expenses), divided by the number of then outstanding public
shares, which redemption will completely extinguish public stockholders' rights
as stockholders (including the right to receive further liquidating
distributions, if any); and (iii) as promptly as reasonably possible following
such redemption, subject to the approval of the remaining stockholders and the
board of directors, liquidate and dissolve, subject in each case, to our
obligations under Delaware law to provide for claims of creditors and the
requirements of other applicable law.
Results of Operations
Our entire activity since inception up to December 15, 2020 was related to our
formation and IPO. Since the IPO, our activity has been limited to the search
for a prospective initial business combination target. We will not generate any
operating revenues until the consummation of our initial business combination.
We expect to incur increased expenses as a result of being a public company (for
legal, financial reporting, accounting and auditing compliance), as well as for
due diligence expenses.
For the period from July 31, 2020 (inception) through December 31, 2020, we had
net loss of $2,959,000, which consisted of $109,000 in general and
administrative expenses, $84,000 in franchise tax expense, $411,000 of financing
costs - derivative warrant liabilities, and $2,356,000 loss from changes in fair
value of derivative warrant liabilities, offset by $325 in interest and
investment income in the Trust Account.

                                       61

--------------------------------------------------------------------------------

Table of Contents


  Index to Financial Statements
As a result of the restatement described in Note 2 of the notes to the financial
statements included herein, we classify the warrants issued in connection with
our IPO and private placement as liabilities at their fair value and adjust the
warrant instruments to fair value at each reporting period. These liabilities
are subject to
re-measurement
at each balance sheet date until exercised, and any change in fair value is
recognized in our statement of operations. For the period from July 31, 2020
(inception) through December 31, 2020, the change in fair value of warrants was
an increase in liabilities of $2,356,000.
Liquidity and Going Concern
As of December 31, 2020, we had $1.2 million outside of the trust account and
$1.4 million of working capital, excluding amount of franchise tax payable.
Our liquidity needs to date have been satisfied through a payment of $25,000
from our sponsor to cover certain on our IPO in exchange for the issuance of the
founder shares, and loan proceeds from the sponsor of $400,000 under a
promissory note. We repaid the promissory note in full on December 15, 2020,
concurrent with the closing of our IPO. Subsequent to the closing of the IPO,
our liquidity needs have been satisfied through the net proceeds from the IPO
and the private placement that are held outside of the trust account.
In connection with the Company's assessment of going concern considerations in
accordance with FASB Accounting Standards Update ("ASU")
2014-15,
"Disclosures of Uncertainties about an Entity's Ability to Continue as a Going
Concern," management has determined that the mandatory liquidation and
subsequent dissolution raises substantial doubt about the Company's ability to
continue as a going concern. No adjustments have been made to the carrying
amounts of assets or liabilities should the Company be required to liquidate
after June 15, 2022. The financial statements do not include any adjustment that
might be necessary if the Company is unable to continue as a going concern.
On January 30, 2020, the World Health Organization, or WHO, announced a global
health emergency because of a new strain of coronavirus
(COVID-19).
In March 2020, the WHO classified the
COVID-19
outbreak as a pandemic, based on the rapid increase in exposure globally. The
full impact of the
COVID-19
pandemic continues to evolve. The impact of the
COVID-19
pandemic on our results of operations, financial position and cash flows will
depend on future developments, including the duration and spread of the pandemic
and related advisories and restrictions. These developments and the impact of
the
COVID-19
pandemic on the financial markets and the overall economy are highly uncertain
and cannot be predicted. If the financial markets and/or the overall economy are
impacted for an extended period, our results of operations, financial position
and cash flows may be materially adversely affected. Additionally, our ability
to complete an initial business combination, may be adversely affected due to
significant governmental measures being implemented to contain the
COVID-19
pandemic or treat its impact, including travel restrictions, the shutdown of
businesses and quarantines, among others, which may limit our ability to have
meetings with potential investors or affect the ability of a potential target
company's personnel, vendors and service providers to negotiate and consummate
an initial business combination in a timely manner. Our ability to consummate an
initial business combination may also depend on our ability to raise additional
equity and debt financing, which may be impacted by the
COVID-19
pandemic.
Commitments and Contingencies
Registration Rights
The holders of the founder shares and private placement warrants are entitled to
registration rights pursuant to a registration rights agreement we entered into
in connection with our IPO. The holders of these securities are entitled to make
up to three demands that we register such securities, subject to specified
conditions. In addition, the holders have certain "piggy-back" registration
rights with respect to registration statements filed subsequent to the
consummation of the business combination. We will bear the expenses incurred in
connection with the filing of any such registration statements. However, the
registration rights agreement provides that we will not be required to effect or
permit any registration or cause any registration statement to become effective
until termination of the applicable
lock-up
period.

                                       62

--------------------------------------------------------------------------------

Table of Contents


  Index to Financial Statements
Underwriting Agreement
The underwriters were entitled to an underwriting discount of $0.20 per unit, or
$3.45 million in the aggregate, paid upon the closing of the IPO. The
underwriters also made a payment to us in an amount equal to 1.0% of the gross
proceeds of the IPO, or $1.7 million in the aggregate to reimburse certain of
our expenses.
An additional fee of $0.40 per unit, or $6.9 million in the aggregate will be
payable to the underwriters for deferred underwriting commissions. The deferred
underwriting commissions will become payable to the underwriters from the
amounts held in the trust account solely in the event that we complete our
initial business combination, subject to the terms of the underwriting
agreement.
Deferred Consulting Fees
In September 2020, we entered into an engagement letter with a consultant to
obtain advisory services in connection with our search for a business
combination target, pursuant to which we agreed to pay a $10,000 initial fee
upon execution and a deferred success fee of $50,000 upon the consummation of
our initial business combination.
Critical Accounting Policies and Estimates
Management's discussion and analysis of our financial condition and results of
operations is based on our financial statements, which have been prepared in
accordance with accounting principles generally accepted in the United States of
America. The preparation of our financial statements requires us to make
estimates and judgments that affect the reported amounts of assets, liabilities,
revenues and expenses and the disclosure of contingent assets and liabilities in
our financial statements. On an ongoing basis, we evaluate our estimates and
judgments, including those related to fair value of financial instruments and
accrued expenses. We base our estimates on historical experience, known trends
and events and various other factors that we believe to be reasonable under the
circumstances, the results of which form the basis for making judgments about
the carrying values of assets and liabilities that are not readily apparent from
other sources. Actual results may differ from these estimates under different
assumptions or conditions. We have identified the following as our critical
accounting policies:
Investments Held in Trust Account
Our portfolio of investments held in trust is comprised solely of U.S.
government securities, within the meaning set forth in Section 2(a)(16) of the
Investment Company Act of 1940, as amended, with a maturity of 185 days or less,
or investments in money market funds that invest in U.S. government securities,
or a combination thereof. Our investments held in the trust account are
classified as trading securities. Trading securities are presented on the
balance sheet at fair value at the end of each reporting period. Gains and
losses resulting from the change in fair value of these investments are included
in net gain from investments held in trust account in the accompanying statement
of operations. The estimated fair values of investments held in the trust
account are determined using available market information.
Class A Common Stock Subject to Possible Redemption
We account for its Class A common stock subject to possible redemption in
accordance with the guidance in ASC Topic 480
Distinguishing Liabilities from Equity
. Class A common stock subject to mandatory redemption (if any) is classified as
liability instruments and are measured at fair value. Conditionally redeemable
Class A common stock (including Class A common stock that features redemption
rights that are either within the control of the holder or subject to redemption
upon the occurrence of uncertain events not solely our control) are classified
as temporary equity. At all other times, Class A common stock is classified as
stockholders' equity. Our Class A common stock feature certain redemption rights
that are considered to be outside of our control and subject to the occurrence
of uncertain future events. Accordingly, as of the Initial Public Offering,
17,250,000 shares of Class A common stock subject to possible redemption are
presented at redemption value as temporary equity, outside of the stockholders'
equity section of our condensed balance sheets.
Effective with the closing of the Initial Public Offering, we recognized the
accretion from initial book value to redemption amount, which, resulted in
charges against additional
paid-in
capital (to the extent available) and accumulated deficit.
Derivative Warrant liabilities
We do not use derivative instruments to hedge exposures to cash flow, market, or
foreign currency risks. We evaluate all of our financial instruments, including
issued stock purchase warrants, to determine if such instruments are derivatives
or contain features that qualify as embedded derivatives, pursuant to ASC 480
and ASC
815-15.
The classification of derivative instruments, including whether such instruments
should be recorded as liabilities or as equity, is
re-assessed
at the end of each reporting period.

                                       63

--------------------------------------------------------------------------------

Table of Contents


  Index to Financial Statements
We issued 8,625,000 warrants to purchase common stock to investors in our IPO
and issued 7,175,000 private placement warrants to our sponsor. All of our
outstanding warrants are recognized as derivative liabilities in accordance with
ASC 815-40.
Accordingly, we recognize the warrant instruments as liabilities at fair value
and adjust the instruments to fair value at each reporting period. The
liabilities are subject to
re-measurement
at each balance sheet date until exercised, and any change in fair value is
recognized in our statement of operations. The fair value of warrants issued in
connection with the IPO was initially and subsequently measured at fair value
using a Monte Carlo simulation model. The fair value of the private placement
warrants was initially and subsequently measured at fair value using
Black-Scholes.
Net Income (Loss) Per Common Stock
We comply with accounting and disclosure requirements of FASB ASC Topic 260,
Earnings Per Share
. We have two classes of shares, which are referred to as Class A common stock
and Class B common stock. Income and losses are shared pro rata between the two
classes of shares. Net income (loss) per common share is calculated by dividing
the net income (loss) by the weighted average shares of common stock outstanding
for the respective period.
The calculation of diluted net income (loss) per common stock does not consider
the effect of the warrants issued in connection with the Initial Public Offering
(including exercise of the over-allotment option) and the Private Placement to
purchase an aggregate of 15,800,000 shares of Class A common stock in the
calculation of diluted income (loss) per share, because their exercise is
contingent upon future events and their inclusion would be anti-dilutive under
the treasury stock method. As a result, diluted net income (loss) per share is
the same as basic net income (loss) per share for the period from July 31, 2020
(inception) through December 31, 2020. Accretion associated with the redeemable
Class A common stock is excluded from earnings per share as the redemption value
approximates fair value.
Recent Accounting Pronouncements
Our management does not believe that there are any other recently issued, but
not yet effective, accounting pronouncements, if currently adopted, would have a
material effect on our financial statements.
Off-Balance Sheet Arrangements and Contractual Obligations
As of December 31, 2020, we did not
have any off-balance sheet arrangements
as defined in Item 303(a)(4)(ii)
of Regulation S-K and did
not have any commitments or contractual obligations.

                                       64

--------------------------------------------------------------------------------

Table of Contents


  Index to Financial Statements
JOBS Act
The Jumpstart Our Business Startups Act of 2012, or the JOBS Act, contains
provisions that, among other things, relax certain reporting requirements for
qualifying public companies. We qualify as an "emerging growth company" and
under the JOBS Act are allowed to comply with new or revised accounting
pronouncements based on the effective date for private (not publicly traded)
companies. We have elected to delay the adoption of new or revised accounting
standards, and as a result, we may not comply with new or revised accounting
standards on the relevant dates on which adoption of such standards is required
for
non-emerging
growth companies. As a result, the financial statements may not be comparable to
companies that comply with new or revised accounting pronouncements as of public
company effective dates.
Additionally, we are in the process of evaluating the benefits of relying on the
other reduced reporting requirements provided by the JOBS Act. Subject to
certain conditions set forth in the JOBS Act, if, as an "emerging growth
company," we choose to rely on such exemptions we may not be required to, among
other things, (i) provide an auditor's attestation report on our system of
internal controls over financial reporting pursuant to Section 404, (ii) provide
all of the compensation disclosure that may be required of
non-emerging
growth public companies under the Dodd-Frank Wall Street Reform and Consumer
Protection Act, (iii) comply with any requirement that may be adopted by the
PCAOB regarding mandatory audit firm rotation or a supplement to the auditor's
report providing additional information about the audit and the financial
statements (auditor discussion and analysis) and (iv) disclose certain executive
compensation related items such as the correlation between executive
compensation and performance and comparisons of the CEO's compensation to median
employee compensation. We will remain an emerging growth company until the
earlier of (1) the last day of the fiscal year (a) following the fifth
anniversary of the completion of our IPO, (b) in which we have total annual
gross revenue of at least $1.07 billion, or (c) in which we are deemed to be a
large accelerated filer, which means the market value of our shares of Class A
common stock that is held by
non-affiliates
equals or exceeds $700 million as of the prior June 30th, and (2) the date on
which we have issued more than $1.0 billion in
non-convertible
debt securities during the prior three-year period.

© Edgar Online, source Glimpses